News

News

ImmPACT Bio Announces Completion of Merger with Kalthera to Progress Next-Generation CAR T Therapies for the Treatment of Cancer

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Extension Of Innovation Partnering Office at Monash University In Collaboration With Victorian State Government To Accelerate The Life-Sciences Hub

Read full story
Other news

Ribon Therapeutics Secures $65 Million Financing

Read full story
Other news

Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)

Read full story
Other news

POINT Biopharma Debuts as Publicly Traded Next-Generation Radiotherapeutics Company

Read full story
In the media

Inside Johnson & Johnson’s Nonstop Hunt for a Coronavirus Vaccine

Read full story
In the media

Driving Innovation In UK Life Sciences

Read full story
Partner news

Vor Biopharma Closes $110 Million Series B Financing

Read full story
Partner news

CVRx Raises $50 Million in New Equity Financing

Read full story
In the media

Investing in innovation – new digital approaches for a new decade

Read full story
Other news

X-Vax Technology Raises $56 Million in Upsized Series A Financing to Advance Lead Herpes Vaccine Program

Read full story
Press release

Janssen Korea Ltd. and Johnson & Johnson Innovation Announce Launch of Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with Seoul Metropolitan Government and Korea Health Industry Development Institute

Read full story
Other news

Future of healthcare discussions held at Health Horizons in Cambridge

Read full story
Other news

BioTarget Competition: Speeding up the Race to Beat Cancer

Read full story
Press release

Johnson & Johnson Innovation Recognizes Women in STEM2D Joint Project with Griffith University

Read full story